Production of HPV vaccine for cervical cancer to start in first quarter of 2023: Adar Poonawala

Oct 21, 2022

New Delhi [India], October 21 : The production of India's first indigenously developed quadrivalent Human Papillomavirus (HPV) "CERVAVAC" vaccine, for the prevention of cervical...

Vaccine for cervical cancer prevention to be available in small quantity in 2023, increased next year: Adar Poonawalla

Jan 25, 2023

Adar Poonawalla said that the availability of the Human Papillomavirus (HPV) vaccine will be little in number this year, however, it would be boosted...

Cost of cervical cancer vaccine Cervavac will be between Rs 200-400: Adar Poonawala

Sep 01, 2022

New Delhi [India], September 1 (ANI: India's first indigenously developed quadrivalent Human Papilloma Virus (qHPV) vaccine will be available at an affordable price, said...

SII CEO thanks PM Modi for support after seeking emergency authorisation of its COVID vaccine

Dec 07, 2020

New Delhi [India], December 7 : After Serum Institute India (SII) applied for the emergency use authorisation of its coronavirus vaccine "COVISHIELD", its CEO...

Covishield production in full swing, says SII's Adar Poonawalla

May 02, 2021

New Delhi [India], May 2 : Adar Poonawalla, CEO of Serum Institute of India (SII) on Saturday night said that the production of COVID-19...

SII stopped production of Covishield vaccine since December 2021, says CEO Adar Poonwalla

Oct 20, 2022

Pune (Maharashtra) [India], October 20 : Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla, on Thursday said that the medical firm...